- Home
- JAKK vs KOD Comparison
JAKK vs KOD Comparison
Compare JAKK & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAKK
- KOD
- Stock Information
- Founded
- JAKK 1995
- KOD 2009
- Country
- JAKK United States
- KOD United States
- Employees
- JAKK N/A
- KOD N/A
- Industry
- JAKK Recreational Games/Products/Toys
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JAKK Consumer Discretionary
- KOD Health Care
- Exchange
- JAKK Nasdaq
- KOD Nasdaq
- Market Cap
- JAKK 231.8M
- KOD 198.4M
- IPO Year
- JAKK 1996
- KOD 2018
- Fundamental
- Price
- JAKK $18.57
- KOD $10.20
- Analyst Decision
- JAKK Strong Buy
- KOD Hold
- Analyst Count
- JAKK 4
- KOD 4
- Target Price
- JAKK $41.75
- KOD $11.75
- AVG Volume (30 Days)
- JAKK 151.1K
- KOD 691.9K
- Earning Date
- JAKK 07-24-2025
- KOD 08-13-2025
- Dividend Yield
- JAKK 5.71%
- KOD N/A
- EPS Growth
- JAKK 25.15
- KOD N/A
- EPS
- JAKK 3.34
- KOD N/A
- Revenue
- JAKK $684,694,000.00
- KOD N/A
- Revenue This Year
- JAKK N/A
- KOD N/A
- Revenue Next Year
- JAKK $4.01
- KOD N/A
- P/E Ratio
- JAKK $5.55
- KOD N/A
- Revenue Growth
- JAKK 1.31
- KOD N/A
- 52 Week Low
- JAKK $16.24
- KOD $1.92
- 52 Week High
- JAKK $35.79
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- JAKK 56.07
- KOD 65.75
- Support Level
- JAKK $17.24
- KOD $8.77
- Resistance Level
- JAKK $17.90
- KOD $11.30
- Average True Range (ATR)
- JAKK 0.56
- KOD 0.99
- MACD
- JAKK 0.23
- KOD 0.02
- Stochastic Oscillator
- JAKK 98.31
- KOD 73.24
About JAKK JAKKS Pacific Inc.
Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells and distributes toys and related kid-targeted consumer products, inclusive of kids indoor and outdoor furniture, costumes and various product lines in the sporting goods and home furnishings space. Its products offering include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: (i) Toys/Consumer Products and (ii) Costumes.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.